Searched for
INDIAN PHARMACOPOEIA COMMISSION
Govt orders safety review of popular weight-loss drugs amid rising demandIndian authorities are increasing vigilance on popular weight loss drugs. Indian Pharmacopoeia Commission will now compile reports on adver...- Budget: Ayush ministry allocated Rs 3,992.90 croreThe budget allocation for the Ministry of Ayush has been increased by 14.15 per cent to Rs 3,992.90 crore for 2025-26. Funds have been desi...
- Health body issues safety warning about commonly-used BP and heart medicinesBeta-blockers, used for irregular heartbeat and hypertension, can cause dangerously low potassium levels, known as hypokalaemia, according ...
- A proper Indian 'Foodocopoeia' neededThe Indian culinary scene still suffers from that same colonial hangover when it comes to codification, with the curricula in desi catering...
- Drugs body flags side effects of heart, Glaucoma medicationsThe Indian Pharmacopoeia Commission has issued a drug safety alert regarding amlodipine and acetazolamide, highlighting potential adverse r...
- India, Cambodia discuss investment treaty, UPI collaborationIndia and Cambodia are in talks to collaborate on UPI-based digital payments to boost trade and tourism, according to the Indian commerce m...
- Ayush Ministry gets Rs 3,712 crore in interim BudgetThe Ayush Ministry's interim Budget allocation for 2024-25 has increased to Rs 3,712.49 crore, up by 23.74% from the revised estimates of R...
- Meftal maker says adverse reaction flagged by IPC is very rareBlue Cross Laboratories, the owner of the Meftal painkiller brand, has clarified that the adverse reaction the Indian Pharmacopoeia Commiss...
- Painkiller Meftal could cause adverse reactions: IPCThe commission, in its alert, stated that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (P...
- Government advisory alerts users about Meftal's risks: Here's everything you need to know about itThe Indian Pharmacopoeia Commission's advisory alerts users about Meftal's dangers, specifically its active ingredient mefenamic acid, link...
- UPSC recommends Rajeev Singh Raghuvanshi as next DCGIThe UPSC recommendation has to be approved by the Health Ministry, followed by approval of the Appointments Committee of Cabinet led by Pri...
- Government in talks with various markets to accept Indian drug normsIndia is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of the US or British norms.
- IPC to become first WHO Collaborating Centre in SE AsiaHealth Secretary BP Sharma said the importance of Pharmacovigilance has increased as there have been changes in the ways people take medici...
- Vigilance important to monitor adverse effects of drugs: JP NaddaHealth Minister JP Nadda today underlined the importance of pharmacovigilance, the monitoring of adverse effects of drugs in the country.
- Cabinet clears merger of CIPL with IPCThe government on Friday cleared the proposal to merge Ghaziabad-based Central Indian Pharmacopoeia Laboratory Indian Pharmacopoeia Commiss...
- Traditional Indian medicines have a world market: RamadossUnion Health Minister Dr Anbumani Ramadoss says concrete steps should be taken to market traditional Indian medicines.
- Ramadoss to release Indian PharmacopoeiaUnion Health and Family Welfare Minister Anbumani Ramadoss will release the Indian Pharmacopoeia 2007 on Tuesday.
- Govt brings out Indian Pharmacopoeia, 2007In an effort to control the quality of medicinal products, the government has brought out the Indian Pharmacopoeia, 2007, which lays down t...
- Panel:Keep medicines in good healthThe government is all set to bring more clarity on how pharmaceutical companies should print instructions about storage and transportation ...
- Indian Pharmacopoeia signs MoU with US coThe Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding with US Pharmacopoeia (USP) for cooperation in promoting...
Load More
